Innovative Eyewear (NASDAQ: LUCY) flags proposed $3.1K Rule 144 stock sale

Rhea-AI Filing Summary

Innovative Eyewear Inc (LUCY) has a notice of proposed sale of common stock filed on behalf of officer Joaquin Abondano under Rule 144. The notice lists a potential sale of 4,389 common shares through Raymond James & Associates, Inc., with an aggregate market value of $3,120.58 and 6,403,728 shares of common stock outstanding. The securities are tied to a 14,800-share RSU grant, with cash as the form of payment. Melissa Fisher signed as a duly authorized representative of Raymond James & Associates, Inc., acting as attorney-in-fact for Joaquin Abondano.

Key Figures

Shares to be sold: 4,389 shares Aggregate market value: $3,120.58 Shares outstanding: 6,403,728 shares +2 more

5 metrics

Shares to be sold 4,389 shares Common stock proposed for sale under Rule 144

Aggregate market value $3,120.58 Value of 4,389 common shares covered by the notice

Shares outstanding 6,403,728 shares Common shares of Innovative Eyewear Inc outstanding

RSU grant size 14,800 shares Common shares underlying the related RSU grant

Approximate date of sale 08/19/2026 Date listed for the proposed Rule 144 sale

Key Terms

Rule 144, Form 144, RSU Grant, attorney-in-fact

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Form 144 regulatory

"144: Filer Information 144: Issuer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

RSU Grant financial

"Common | 08/19/2026 | RSU Grant | Issuer"

attorney-in-fact regulatory

"as attorney-in-fact for Joaquin Abondano"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

What does the Form 144 filing mean for Innovative Eyewear Inc (LUCY)?

The Form 144 gives notice that 4,389 LUCY common shares may be sold under Rule 144. It is a proposed sale by officer Joaquin Abondano and does not itself complete any transaction or set a guaranteed sale amount.

How many Innovative Eyewear (LUCY) shares are covered by this Form 144 notice?

The notice covers a potential sale of 4,389 common shares of Innovative Eyewear Inc. These shares are proposed to be sold through Raymond James & Associates, Inc. on Nasdaq under the Rule 144 resale framework.

What is the aggregate market value of the LUCY shares in this Form 144?

The filing reports an aggregate market value of $3,120.58 for the 4,389 LUCY common shares subject to the proposed Rule 144 sale. This value reflects the filer’s estimate at the time of the notice.

How many Innovative Eyewear (LUCY) shares are outstanding according to the Form 144?

The Form 144 states that 6,403,728 shares of Innovative Eyewear Inc common stock are outstanding. This figure provides context for the relative size of the 4,389-share proposed sale under Rule 144.

What equity award is related to the proposed LUCY share sale?

The notice links the securities to an RSU grant of 14,800 shares of Innovative Eyewear common stock. The Form 144 indicates the acquisition via RSU grant with cash listed as the nature of payment.

Who is selling LUCY shares and which broker is involved?

The proposed sale is for the account of officer Joaquin Abondano, with Raymond James & Associates, Inc. listed as broker. Melissa Fisher signs as a duly authorized representative and attorney-in-fact for Abondano.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/19/2026 - 04:29 PM Accepted by SEC EDGAR 08/19/2026 - 04:29 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002008020
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Innovative Eyewear Inc
SEC File Number	001-41392
Address of Issuer	11900 BISCAYNE BLVD STE 630 MIAMI FLORIDA 33181
Phone	786-910-1898
Name of Person for Whose Account the Securities are To Be Sold	Abondano Joaquin
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Raymond James & Associates, Inc. 880 Carillon Parkway St. Petersburg FL 33716	4389	3120.58	6403728	08/19/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/19/2026	RSU Grant	Issuer			14800	08/19/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/19/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/09/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Melissa Fisher, as duly authorized representative of Raymond James & Associates, Inc., as attorney-in-fact for Joaquin Abondano
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)